Scaling Impact: Why I’m Excited for the Future of Adipose and Regenerative Medicine in 2026
Returning from the IMCAS World Congress in Paris, I’m struck by how quickly the “regenerative” conversation is evolving. We are moving away from simple volume replacement and toward true tissue regeneration. At Sayenza Biosciences, we are positioned at the heart of this shift. The State of the Field in 2026 The global regenerative medicine market […]
